IOTA Pharmaceuticals


IOTA Pharmaceuticals

Fragment - based Drug Discovery
Neglected Parasitic Disease
Glioma & Glioblastoma
About IOTA Pharmaceuticals

IOTA has a close working relationship with the Department of Medicinal Chemistry at the Free University of Amsterdam.

Built on drug discovery expertise in the field of pharmacological targets such as the histamine, acetylcholine, chemokine and nuclear hormone receptors, and led by IOTA co-founder Dr Iwan de Esch, the VU Discovery team has extensive experience working in drug discovery projects alongside both international pharma and academic partners.

VU Discovery Studies
Histamine Receptors Nicotinic AChR / AChBPs
Kinases Nuclear Hormone Receptors
Chemokine Receptors